Atlas Trials

M-TACE Treatment for Unresectable Hepatocellular Carcinoma

Clinical trial NCT05875558 · UNKNOWN

Trial details

NCT number
NCT05875558
Sponsor
Shanghai Zhongshan Hospital
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Hepatocellular Carcinoma
Start date
2022-07-01
Primary completion
2023-12-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.